Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Class A Common Stock, par value $0.001 per share
- Shares outstanding
- 72,325,000
- Total 13F shares
- 52,988,211
- Share change
- +1,720,488
- Total reported value
- $1,917,110,562
- Put/Call ratio
- 216%
- Price per share
- $36.18
- Number of holders
- 169
- Value change
- +$57,678,654
- Number of buys
- 102
- Number of sells
- 78
Quarterly Holders Quick Answers
What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92337R101:
Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
|
Company |
7.3%
|
5,265,000
|
$227,026,800 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
3,318,964
|
$143,113,727 | — | 31 Mar 2024 | |
| Commodore Capital LP |
13F
3/4/5
|
Company · 10%+ Owner |
4.4%
|
3,165,000
|
$136,474,800 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
4.3%
|
3,123,268
|
$134,675,317 | — | 31 Mar 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
3.9%
|
2,793,987
|
$120,476,719 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.3%
|
2,393,029
|
$103,189,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
2,350,727
|
$101,363,348 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
2,148,714
|
$92,652,547 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
2.5%
|
1,823,781
|
$78,641,437 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
1,536,790
|
$66,266,386 | — | 31 Mar 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
2.1%
|
1,526,787
|
$65,835,055 | — | 31 Mar 2024 | |
| Sofinnova Venture Partners X, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,467,156
|
$62,408,808 | — | 06 Feb 2023 | |
| Emster Kurt von |
3/4/5
|
Director |
—
mixed-class rows
|
2,987,984
mixed-class rows
|
$53,605,062 | — | 17 May 2021 | |
| Abingworth LLP |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
2,970,156
mixed-class rows
|
$53,284,158 | — | 13 May 2021 | |
| Carlyle Group Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,960,231
|
$53,284,158 | — | 17 Aug 2022 | |
| Holocene Advisors, LP |
13F
|
Company |
1.7%
|
1,207,380
|
$52,062,226 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.6%
|
1,175,148
|
$50,672,382 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.4%
|
1,011,550
|
$43,618,036 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
961,309
|
$41,457,484 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.3%
|
947,097
|
$40,838,823 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
837,195
|
$36,099,848 | — | 31 Mar 2024 | |
| Longitude Capital Partners IV, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,714,285
|
$30,857,130 | — | 06 Feb 2023 | |
| Longitude Prime Partners, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,714,285
|
$30,857,130 | — | 06 Feb 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.98%
|
710,000
|
$30,615,200 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.93%
|
675,872
|
$29,143,601 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.93%
|
675,000
|
$29,106,000 | — | 31 Mar 2024 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.89%
|
645,501
|
$27,834,003 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.88%
|
636,994
|
$27,467,182 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.83%
|
601,036
|
$25,916,672 | — | 31 Mar 2024 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.82%
|
594,091
|
$25,617,204 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.8%
|
575,000
|
$24,794,000 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.77%
|
559,790
|
$24,138,144 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.7%
|
506,019
|
$21,819,539 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.66%
|
480,519
|
$20,719,980 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.65%
|
470,000
|
$20,266,400 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
446,905
|
$19,270,544 | — | 31 Mar 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.6%
|
436,133
|
$18,806,055 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.53%
|
383,500
|
$16,536,520 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
372,454
|
$16,060,216 | — | 31 Mar 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.5%
|
360,000
|
$15,523,200 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.49%
|
351,653
|
$15,163,277 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.47%
|
341,168
|
$14,711,164 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.47%
|
338,425
|
$14,592,886 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.46%
|
335,564
|
$14,469,520 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.43%
|
307,610
|
$13,264,143 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
0.38%
|
272,078
|
$11,732,003 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
257,257
|
$11,092,922 | — | 31 Mar 2024 | |
| Alphabet Inc. |
13F
|
Company |
0.33%
|
241,264
|
$10,403,303 | — | 31 Mar 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.31%
|
225,581
|
$9,727,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
200,152
|
$8,630,554 | — | 31 Mar 2024 |
Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q2 2024
As of 30 Jun 2024,
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,988,211 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., FMR LLC, Sofinnova Investments, Inc., VANGUARD GROUP INC, COMMODORE CAPITAL LP, STATE STREET CORP, Eversept Partners, LP, and Holocene Advisors, LP.
This page lists
169
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
157
Q2 2024 holders
169
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.